Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,831 | -17,215 | -17,473 | -13,246 | -21,870 |
| Depreciation Amortization | 4,754 | 4,700 | 4,646 | 2,310 | 8,628 |
| Accounts receivable | 63 | 1,747 | 23 | 965 | -701 |
| Accounts payable and accrued liabilities | 1,732 | -1,718 | -981 | -857 | 1,577 |
| Other Working Capital | 553 | 1,336 | -685 | -524 | -905 |
| Other Operating Activity | 5,006 | 2,290 | 9,674 | 7,926 | 4,214 |
| Operating Cash Flow | $-9,724 | $-8,860 | $-4,795 | $-3,424 | $-9,056 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 35,198 | 35,205 | -7 | -1 | -50 |
| Investing Cash Flow | $35,198 | $35,205 | $-7 | $-1 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 15,000 | 15,000 | N/A | N/A |
| Debt Repayment | -42,156 | -42,156 | N/A | N/A | N/A |
| Common Stock Issued | 11,723 | 11,644 | N/A | N/A | 11,456 |
| Common Stock Repurchased | -3,122 | -3,122 | -28 | -26 | -92 |
| Dividend Paid | -30 | -23 | -15 | -8 | -32 |
| Financing Cash Flow | $-18,585 | $-18,657 | $14,957 | $-33 | $11,333 |
| Exchange Rate Effect | -16 | -12 | -34 | -15 | 33 |
| Beginning Cash Position | 14,758 | 14,758 | 14,758 | 14,758 | 12,497 |
| End Cash Position | 21,631 | 22,435 | 24,878 | 11,284 | 14,758 |
| Net Cash Flow | $6,873 | $7,677 | $10,121 | $-3,473 | $2,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,724 | -8,860 | -4,795 | -3,424 | -9,056 |
| Capital Expenditure | -42 | -35 | -7 | -1 | -50 |
| Free Cash Flow | -9,766 | -8,895 | -4,802 | -3,425 | -9,106 |